Gamete Regulation and Family Protection in a Post-Dobbs World
When regulating assisted reproduction, it is important to proceed cautiously and to consider how proposals may adversely impact family recognition.
When regulating assisted reproduction, it is important to proceed cautiously and to consider how proposals may adversely impact family recognition.
How did we get to a place where women must work an “infertility shift” beyond their full-time jobs to access medical care?
Mapping the growth of U.S. innovation in the life sciences and computing fields from 1976-2021 through publicly available patent data.
An explanation of the key patents at stake in the intellectual property dispute between Moderna and Pfizer/BioNTech over COVID-19 vaccines.
In a post-Dobbs world, more women will find the technologies they rely on for their health turned against them as tools of surveillance.
Four potential avenues for structuring a societal discourse on reproductive genetic innovation in the U.S.
The Truth Pill is a monumental work that convincingly shows that drug regulation is but a myth in India.
With COVID-19 vaccination rates lagging, it’s well past time for city, state, and federal governments to enact paid sick leave.
Advertisers are trying to market to us while we dream — a troubling and potentially illegal new reality.
The legal documents that every adult in the U.S. should have to help ensure their finances and health care are well-managed.